EGFR/estrogen interactions: role in bronchioalveolar carcinoma and gender differences in the efficacy of antiangiogenic therapy

Targeted Therapeutics Research Award
Funded equally by LUNGevity Foundation and Joan's Legacy
John Heymach, MD, PhD
MD Anderson Cancer Center
Houston
TX

The role of the hormone estrogen in the development of lung cancer has been established. Dr. Heymach is studying how estrogen affects signaling by the EGFR gene and secretion of proteins that fuel the development of new blood vessels necessary to sustain the growth of the cancer.